RB1 and neoplasm: Results from GEPIA indicated a positive association of RB1 expression with CTLA4, LAG3 and CD274 in tumor tissues (P <0.05, Figures 6A, C, E), whereas there was no significant association with other immune checkpoint molecules (Figures 6B, D).